References
- Gupta AK, Bluhm R. Seborrheic dermatitis. J. Eur. Acad. Dermatol. Venerol.18(1), 13–26 (2004).
- Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am. Fam. Phys.74(1), 125–130 (2006).
- Herrera-Arellano A, Jiménez-Ferrer E, Vega-Pimentel AM et al. Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole. Planta Med.70(6), 483–488 (2004).
- Janniger CK, Schwartz RA. Seborrheic dermatitis. Am. Fam. Physician.52(1), 149–155, 159–160 (1995).
- Ro BI, Dawson TL. The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J. Investig. Dermatol. Symp. Proc.10(3), 194–197 (2005).
- Elewski BE. Clinical diagnosis of common scalp disorders. J. Investig. Dermatol. Symp. Proc.10(3), 190–193 (2005).
- Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J. Am. Acad. Dermatol.51(5), 785–798 (2004).
- DeAngelis YM, Gemmer CM, Kaczvinsky JR, Kenneally DC, Schwartz JR, Dawson TL Jr. Three etiologic facets of dandruff and seborrheic dermatitis: malassezia fungi, sebaceous lipids, and individual sensitivity. J. Investig. Dermatol. Symp. Proc.10(3), 295–297 (2005).
- Harding CR, Moore AE, Rogers JS, Meldrum H, Scott AE, McGlone FP. Dandruff: a condition characterized by decreased levels of intercellular lipids in scalp stratum corneum and impaired barrier function. Arch. Dermatol. Res.294(5), 221–230 (2002).
- Ostlere LS, Taylor CR, Harris DW, Rustin MH, Wright S, Johnson M. Skin surface lipids in HIV-positive patients with and without seborrheic dermatitis. Int. J. Dermatol.35(4), 276–279 (1996).
- Sandyk R. Seborrhea and persistent tardive dyskinesia. Int. J. Neurosci.50(3–4), 223–226 (1990).
- Maietta G, Fornaro P, Rongioletti F, Rebora A. Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm. Venereol. (Stockholm)70(5), 432–434 (1990).
- Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin. Exp. Med.19(3), 210–216 (1994).
- Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J. Invest. Dermatol. Symp. Proc.9(2), 169–180 (2004).
- Szepietowski J, Salomon J, Finlay AY et al. Dermatology Life Quality Index (DLQI): Polish version. Dermatol. Klin.6(2), 63–70 (2004).
- Hongbo Y, Thomas CL, Harrison MA et al. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? J. Invest. Dermatol.125(4), 659–664 (2005).
- Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J. Invest. Dermatol.107(5), 707–713 (1996).
- Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch. Dermatol.133(11), 1433–1440 (1997).
- Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br. J. Dermatol.143(5), 979–982 (2000).
- Öztas P, Calikoglu E, Ctin I. Psychiatric tests in seborrhoeic dermatitis. Acta Derm. Venereol. (Stockholm)85(1), 68–69 (2004).
- Szepietowski JC, Reich A, Wesoowska-Szepietowska E, Baran E. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Dermatol. Klin.9(Suppl. 1), 41 (2007).
- Peyri J, Lleonart M; the Spanish Group of the SEBDERM study. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Actas Dermatosifiliogr.98(7), 476–482 (2007).
- Szepietowski JC, Reich A, Pacan P, Garlowska E, Baran E. Evaluation of quality of life in patients suffering from toenail onychomycosis by Polish version of an International Onychomycosis-specific Questionnaire. J. Eur. Acad. Dermatol. Venereol.21(4), 491–496 (2007).
- Szepietowski JC, Reich A, Wozniak M, Baran E. Evaluation of quality of life in patients with onychomycosis using the Polish version of Dermatology Life Quality Index. Mikol. Lek.13(3), 193–198 (2006).
- Nowicka D, Reich A, Szepietowski J. Psychological impact of androgenetic alopecia. Dermatol. Klin.7(1), 35–36 (2005).
- Reich A, Nowicka D, Szepietowski J. Quality of life among men suffering from androgenetic alopecia. Dermatol. Klin.7(2), 79–81 (2005).
- Reich A, Hrehorow E, Szepietowski JC. Quality of life of patients with psoriasis: relationship with pruritus, stress and symptoms of depression. Dermatol. Klin.9(Suppl. 1), 47–48 (2007).
- Reich A, Chrostowska-Plak D, Szepietowski JC. The influence of itching on atopic dermatitis patients’ well-being. Acta Derm. Venereol (Stockholm)87(5), 471–472 (2007).
- Misery L, Touboul S, Vinçot C et al. Stress et dermatite séborrhéique. Ann. Dermatol. Venereol.134(11), 833–837 (2007).
- Chen SC, Yeung J, Chren M-M. Scalpdex: a quality-of life instrument for scalp dermatitis. Arch. Dermatol.138(6), 803–807 (2002).
- Both H, Essink-Bos M-L, Busschbach J, Nijsten T. Critical review of generic and dermatology-specific health-related quality of life instruments. J. Invest. Dermatol.127(12), 2726–2739 (2007).